155 related articles for article (PubMed ID: 33840062)
1. Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug-Drug Interactions.
Willemin ME; Van Der Made TK; Pijpers I; Dillen L; Kunze A; Jonkers S; Steemans K; Tuytelaars A; Jacobs F; Monshouwer M; Scotcher D; Rostami-Hodjegan A; Galetin A; Snoeys J
Clin Pharmacokinet; 2021 Sep; 60(9):1187-1199. PubMed ID: 33840062
[TBL] [Abstract][Full Text] [Related]
2. Discovery and Validation of Pyridoxic Acid and Homovanillic Acid as Novel Endogenous Plasma Biomarkers of Organic Anion Transporter (OAT) 1 and OAT3 in Cynomolgus Monkeys.
Shen H; Nelson DM; Oliveira RV; Zhang Y; Mcnaney CA; Gu X; Chen W; Su C; Reily MD; Shipkova PA; Gan J; Lai Y; Marathe P; Humphreys WG
Drug Metab Dispos; 2018 Feb; 46(2):178-188. PubMed ID: 29162614
[TBL] [Abstract][Full Text] [Related]
3. Investigation of Endogenous Compounds Applicable to Drug-Drug Interaction Studies Involving the Renal Organic Anion Transporters, OAT1 and OAT3, in Humans.
Tsuruya Y; Kato K; Sano Y; Imamura Y; Maeda K; Kumagai Y; Sugiyama Y; Kusuhara H
Drug Metab Dispos; 2016 Dec; 44(12):1925-1933. PubMed ID: 27638508
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Elimination Pathways and the Feasibility of Endogenous Metabolites as Biomarkers of Organic Anion Transporter 1/3 Inhibition in Cynomolgus Monkeys.
Liu R; Hao J; Zhao X; Lai Y
Drug Metab Dispos; 2023 Jul; 51(7):844-850. PubMed ID: 37059471
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the Validity of Pyridoxic Acid (PDA) as a Plasma-Based Endogenous Probe for OAT1 and OAT3 Function in Healthy Subjects.
Shen H; Holenarsipur VK; Mariappan TT; Drexler DM; Cantone JL; Rajanna P; Singh Gautam S; Zhang Y; Gan J; Shipkova PA; Marathe P; Humphreys WG
J Pharmacol Exp Ther; 2019 Jan; 368(1):136-145. PubMed ID: 30361237
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetic modeling and simulation to support qualification of pyridoxic acid as endogenous biomarker of OAT1/3 renal transporters.
Ahmad A; Ogungbenro K; Kunze A; Jacobs F; Snoeys J; Rostami-Hodjegan A; Galetin A
CPT Pharmacometrics Syst Pharmacol; 2021 May; 10(5):467-477. PubMed ID: 33704919
[TBL] [Abstract][Full Text] [Related]
7. Effect of probenecid on blood levels and renal elimination of furosemide and endogenous compounds in rats: Discovery of putative organic anion transporter biomarkers.
Thakur A; Saradhi Mettu V; Singh DK; Prasad B
Biochem Pharmacol; 2023 Dec; 218():115867. PubMed ID: 37866801
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans.
Maeda K; Tian Y; Fujita T; Ikeda Y; Kumagai Y; Kondo T; Tanabe K; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
Eur J Pharm Sci; 2014 Aug; 59():94-103. PubMed ID: 24747579
[TBL] [Abstract][Full Text] [Related]
9. Development of 4-Pyridoxic Acid PBPK Model to Support Biomarker-Informed Evaluation of OAT1/3 Inhibition and Effect of Chronic Kidney Disease.
Tan SPF; Willemin ME; Snoeys J; Shen H; Rostami-Hodjegan A; Scotcher D; Galetin A
Clin Pharmacol Ther; 2023 Dec; 114(6):1243-1253. PubMed ID: 37620246
[TBL] [Abstract][Full Text] [Related]
10. Endogenous Plasma Kynurenic Acid in Human: A Newly Discovered Biomarker for Drug-Drug Interactions Involving Organic Anion Transporter 1 and 3 Inhibition.
Tang J; Shen H; Zhao X; Holenarsipur VK; Mariappan TT; Zhang Y; Panfen E; Zheng J; Humphreys WG; Lai Y
Drug Metab Dispos; 2021 Dec; 49(12):1063-1069. PubMed ID: 34599018
[TBL] [Abstract][Full Text] [Related]
11. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Prediction of Human Renal Clearance and Drug-Drug Interactions of Organic Anion Transporter Substrates Using In Vitro Transport Data: A Relative Activity Factor Approach.
Mathialagan S; Piotrowski MA; Tess DA; Feng B; Litchfield J; Varma MV
Drug Metab Dispos; 2017 Apr; 45(4):409-417. PubMed ID: 28179375
[TBL] [Abstract][Full Text] [Related]
13. Drug Metabolites Potently Inhibit Renal Organic Anion Transporters, OAT1 and OAT3.
Zou L; Matsson P; Stecula A; Ngo HX; Zur AA; Giacomini KM
J Pharm Sci; 2021 Jan; 110(1):347-353. PubMed ID: 32910949
[TBL] [Abstract][Full Text] [Related]
14. Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)].
Xu G; Bhatnagar V; Wen G; Hamilton BA; Eraly SA; Nigam SK
Kidney Int; 2005 Oct; 68(4):1491-9. PubMed ID: 16164626
[TBL] [Abstract][Full Text] [Related]
15. Differential interactions of the β-lactam cloxacillin with human renal organic anion transporters (OATs).
Lalanne S; Le Vée M; Lemaitre F; Le Corre P; Verdier MC; Fardel O
Fundam Clin Pharmacol; 2020 Aug; 34(4):476-483. PubMed ID: 32100322
[TBL] [Abstract][Full Text] [Related]
16. A Human Renal Proximal Tubule Cell Line with Stable Organic Anion Transporter 1 and 3 Expression Predictive for Antiviral-Induced Toxicity.
Nieskens TT; Peters JG; Schreurs MJ; Smits N; Woestenenk R; Jansen K; van der Made TK; Röring M; Hilgendorf C; Wilmer MJ; Masereeuw R
AAPS J; 2016 Mar; 18(2):465-75. PubMed ID: 26821801
[TBL] [Abstract][Full Text] [Related]
17. Role of organic anion transporter 3 in the renal excretion of biapenem and potential drug-drug interactions.
Li W; Jiao Z; Liu Y; Yao J; Li G; Dong J
Eur J Pharm Sci; 2021 Jul; 162():105814. PubMed ID: 33753216
[TBL] [Abstract][Full Text] [Related]
18. 6β-Hydroxycortisol is an endogenous probe for evaluation of drug-drug interactions involving a multispecific renal organic anion transporter, OAT3/SLC22A8, in healthy subjects.
Imamura Y; Tsuruya Y; Damme K; Heer D; Kumagai Y; Maeda K; Murayama N; Okudaira N; Kurihara A; Izumi T; Sugiyama Y; Kusuhara H
Drug Metab Dispos; 2014 Apr; 42(4):685-94. PubMed ID: 24487120
[TBL] [Abstract][Full Text] [Related]
19. Prediction of renal transporter-mediated drug-drug interactions for a drug which is an OAT substrate and inhibitor using PBPK modelling.
Ball K; Jamier T; Parmentier Y; Denizot C; Mallier A; Chenel M
Eur J Pharm Sci; 2017 Aug; 106():122-132. PubMed ID: 28552429
[TBL] [Abstract][Full Text] [Related]
20. Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human kidney drug transporters.
Han YH; Busler D; Hong Y; Tian Y; Chen C; Rodrigues AD
Drug Metab Dispos; 2010 Jul; 38(7):1064-71. PubMed ID: 20360303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
